004 - Enabling Vaccine Manufacturing and Viral Vector Production using the iCELLis - a single-use, automated, and closed manufacturing platform
In this podcast, we were fortunate to have a group of experts for a panel discussion on vaccine manufacturing and viral vector production.
- Hanna P. Lesch, PhD, Research and Development Director at Finvector Vision Therapies
- Jose Castillo, PhD, Co-Founder and CTO of Univercells
- Mario Philips, Vice President and General Manager, Single-Use Technologies, Pall Life Sciences
- Fabien Moncaubeig, Head of Cell Culture Technologies, Pall Life Sciences